Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bayer's BAY-80-6946 induces regression in tumor models

May 19, 2010

New CREB-mediated gene transcription inhibitors claimed by U.S. scientists

May 19, 2010

Novel oncolytic virus NTX-010 studied for SCLC in new phase II trial

May 18, 2010

Encouraging preliminary safety results from phase II trial of pixantrone reported

May 18, 2010

LA-480 inhibits HGF-dependent and independent c-Met signaling in preclinical study

May 18, 2010

ArQule presents preclinical data on novel Raf kinase B and C inhibitors

May 18, 2010

Novel c-Met inhibitors claimed by Vertex

May 18, 2010

Novel Erk/PI3K inhibitors with potent preclinical activity described by AEterna Zentaris

May 18, 2010

SciClone provides update on clinical program for SCV-07 in oral mucositis

May 17, 2010

SRI International's SR-16388 has promise for multiple myeloma

May 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026